Volume 91, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Cutaneous leishmaniasis is rarely seen in the United States. Four Cuban immigrants traveled along the same route at different times from Cuba to Ecuador, then northward, including through the Darién Jungle in Panama. These patients had chronic ulcerative non-healing skin lesions and were given a diagnosis of leishmaniasis.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Minodier P, Parola P, , 2007. Cutaneous leishmaniasis treatment. Travel Med Infect Dis 5: 150158.[Crossref] [Google Scholar]
  2. Christensen HA, de Vasquez AM, Petersen JL, , 1999. Short report epidemiologic studies on cutaneous leishmaniasis in eastern Panama. Am J Trop Med Hyg 60: 5457. [Google Scholar]
  3. Bethancourt Y, , 2012. Leishmaniasis Causa Dolor en Capira. Panama City, Panama: La Estrella. [Google Scholar]
  4. Antinori S, Schifanella L, Corbellino M, , 2012. Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis 31: 109118.[Crossref] [Google Scholar]
  5. Meyerhoff A, , 1999. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 28: 4248, discussion 49–51.[Crossref] [Google Scholar]
  6. Wortmann G, Zapor M, Ressner R, Fraser S, Hartzell J, Pierson J, Weintrob A, Magill A, , 2010. Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis. Am J Trop Med Hyg 83: 10281033.[Crossref] [Google Scholar]
  7. Nonata R, Sampaio R, Marsden PD, , 1997. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome. Trans R Soc Trop Med Hyg 91: 77.[Crossref] [Google Scholar]
  8. Solomon M, Baum S, Barzilai A, Scope A, Trau H, Schwartz E, , 2007. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis . J Am Acad Dermatol 56: 612616.[Crossref] [Google Scholar]
  9. Sampaio SA, Godoy JT, Paiva L, Dillon NL, da Lacaz CS, , 1960. The treatment of American (mucocutaneous) leishmaniasis with amphotericin B. Arch Dermatol 82: 627635.[Crossref] [Google Scholar]
  10. Murray HW, , 2012. Leishmaniasis in the United States: treatment in 2012. Am J Trop Med Hyg 86: 434440.[Crossref] [Google Scholar]
  11. Solomon M, Pavlotzky F, Barzilai A, Schwartz E, , 2013. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers. J Am Acad Dermatol 68: 284289.[Crossref] [Google Scholar]
  12. Brown M, Noursadeghi M, Boyle J, Davidson RN, , 2005. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Br J Dermatol 153: 203205.[Crossref] [Google Scholar]
  13. Marsden PD, , 1986. Mucosal leishmaniasis (“espundia” Escomel, 1911). Trans R Soc Trop Med Hyg 80: 859876.[Crossref] [Google Scholar]
  14. Amato VS, Tuon FF, Bacha HA, Neto VA, Nicodemo AC, , 2008. Mucosal leishmaniasis. Current scenario and prospects for treatment. Acta Trop 105: 19.[Crossref] [Google Scholar]
  15. Davies CR, Reithinger R, Campbell-Lendrum D, Feliciangeli D, Borges R, Rodriguez N, , 2000. The epidemiology and control of leishmaniasis in Andean countries. Cad Saude Publica 16: 925950.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 27 Feb 2014
  • Accepted : 22 Apr 2014
  • Published online : 06 Aug 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error